As the PTPRD gene is associated with blood pressure response to atenolol32, this difference in the prescription rate of β-blockers may be the reason that previous GWASs discovered an association with resistant hypertension in the PTPRD region, and that we could not find a susceptibility locus near the PTPRD gene. This evidence concerns the gene PTPRD and Hypertension resistant to conventional therapy.